Pharmaceutical Technology

MAY 26, 2023

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. This high compound annual growth rate of 23.6%

Immunization 105

Immunization Vaccines Compounding Insurance 105

PharmaShots

MARCH 14, 2023

The act includes drugs, vaccines, and therapeutics that are intended to treat a disease affecting <200,000 American citizens. With AI-aided research, it becomes relatively easier to select the right compound. Hence, the cost burden comes on the patients and makes drugs expensive for the patient.

FDA 40

FDA Immunization Compounding Vaccines 40

Pharmaceutical Technology

JULY 23, 2008

With expensive new treatments, increasing numbers of patients in chemotherapy in major markets and developing nations like China, Brazil and Russia investing more in treating and diagnosing cancer, IMS predicts a compound growth rate of 12–15% and tips the global market to reach $80bn by 2012.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Chemotherapy 40

ISPE

AUGUST 30, 2022

With shortages, regulatory complexity is compounded due to differences in submission and data requirements from various regulatory agencies. Published May 2012. Burke, PhD. 1 September 2022. A reliable supply of raw materials is critical to maintain a robust supply chain to serve patients globally. Published 2008.

Documentation 52

Documentation FDA Packaging Communication 52

PharmaShots

FEBRUARY 20, 2023

Since time immemorial, plants have been widely used as a source of medicinal compounds. Medicago, has a technology called Proficia through which the company has developed Covifenz, a plant based VLP, recombinant, adjuvanted vaccine for COVID-19 in collaboration with GSK 5.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Compounding 40

ISPE

MARCH 8, 2023

5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US. 9 , 15 This has led to compounding pharmacies completing high-volume activities such as mass repackaging, thereby increasing the risk of cross-contamination. million vials, 26 had to be recalled and destroyed.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52